Proprioceptive neuromuscular facilitation in adjunct to mirror therapy on clinical recovery ,synkinesis and quality of life in patients with Bell's palsy

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20241001063232N1

Enrollment

Registered

2024-10-20

Start date

2024-02-15

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell palsy is an idiopathic peripheral nerve disorder involving the facial nerve (ie, cranial nerve VII) and manifesting as acute, ipsilateral facial muscle weakness. It affects individuals across multiple ages and both sexes, with an annual incidence ranging from 11.5 to 53.3 per 100,000 persons across multiple populations.. Bell's palsy

Interventions

Intervention 1: Intervention group: The participants randomly allocated in Group A will be received the PNF with mirror therapy (MT). After electrical muscle stimulation proprioceptive neuromuscular f

Eligibility

Sex/Gender

All

Age

20 Years to 50 Years

Inclusion criteria

Inclusion criteria: Aged between 25-50 years Both Male and females Patients with unilateral Bells’ Palsy diagnosed by neurologist Patients with moderate to severe Bell’s palsy (House-Brackmann Scale facial nerve grading 3 and 4) Patients with unilateral bell’s palsy

Exclusion criteria

Exclusion criteria: Patients with Autoimmune/ hematologic disease Patients with Inflammatory disease(e.g. Rheumatoid arthritis) Patients with any neurodegenerative disease Patients with cognitive impairments

Design outcomes

Primary

Measure	Time frame
The House-Brackmann Scale (HBS) is one of several analysis tools that have been developed to quantify facial function and provide reproducible information in measuring the global degree of paresis and paralysis. Timepoint: 9th weeks. Method of measurement: It is a widely accepted system and is simple, sensitive, accurate, and reliable, grading facial function in 6 stages, from normal (HB I) to total paralysis (HB VI).;The Synkinesis Assessment Questionnaire comprises nine questions and is a valid and reliable measurement for synkinesis. It correlates well with the synkinesis aspect of FGS. Timepoint: 9th week. Method of measurement: Chuang et al. introduced a four-category classification: I) Good smile with mild synkinesis, II) Acceptable smile with moderate to severe synkinesis, III) Unacceptable smile with severe synkinesis, and IV) Poor smile with mild synkinesis.;The Facial Clinimetric Evaluation Scale (FaCE) is a patient-based instrument that measures facial impairment and disability in evaluating quality-of-life issues that are caused by facial disability. Timepoint: 9th weeks. Method of measurement: This questionnaire consists of 15 questions on a 5-point Likert Scale and comprises 6 domains: facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function. Total and domain scores range from 0 (worst) to 100 (best). This scale has been used in several studies on patient satisfaction following treatment.	—

Measure

Time frame

The House-Brackmann Scale (HBS) is one of several analysis tools that have been developed to quantify facial function and provide reproducible information in measuring the global degree of paresis and paralysis. Timepoint: 9th weeks. Method of measurement: It is a widely accepted system and is simple, sensitive, accurate, and reliable, grading facial function in 6 stages, from normal (HB I) to total paralysis (HB VI).;The Synkinesis Assessment Questionnaire comprises nine questions and is a valid and reliable measurement for synkinesis. It correlates well with the synkinesis aspect of FGS. Timepoint: 9th week. Method of measurement: Chuang et al. introduced a four-category classification: I) Good smile with mild synkinesis, II) Acceptable smile with moderate to severe synkinesis, III) Unacceptable smile with severe synkinesis, and IV) Poor smile with mild synkinesis.;The Facial Clinimetric Evaluation Scale (FaCE) is a patient-based instrument that measures facial impairment and disability in evaluating quality-of-life issues that are caused by facial disability. Timepoint: 9th weeks. Method of measurement: This questionnaire consists of 15 questions on a 5-point Likert Scale and comprises 6 domains: facial movement, facial comfort, oral function, eye comfort, lacrimal control, and social function. Total and domain scores range from 0 (worst) to 100 (best). This scale has been used in several studies on patient satisfaction following treatment.

—

Countries

Pakistan

Contacts

Public ContactSadia Ghafoor

University of Lahore

sgrana14@outlook.com+92 304 787995

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026